DNA and genetic testing firm 23andMe is in turmoil following a 2023 data breach and its ongoing financial decline. The once-pioneering giant now faces an uncertain future as bankruptcy looms over the company, intensifying concerns about what might happen to the genetic data of 23andMe’s some 15 million customers. Best known for its saliva-based test […]
23andMe faces an uncertain future — so does your genetic data Read More »
Genetics testing company 23andMe has filed for Chapter 11 bankruptcy protection in the U.S. to initiate the sale of its assets. Alongside the announcement, the company’s co-founder and CEO Anne Wojcicki separately said she is leaving the company to become an independent bidder for the company. “After a thorough evaluation of strategic alternatives, we have
DNA testing company 23andMe files for bankruptcy protection, CEO resigns Read More »
Last week, Founders Fund partner Delian Asparouhov realized he hadn’t checked on his genetics in a while. He clicked open a dashboard created by Nucleus Genomics, a Founders Fund-backed startup that gets saliva samples sequenced and then compares the DNA results to extensive data linking health issues to genes. Within seconds, he concluded that he
Controversial genetics testing startup Nucleus Genomics raises $14M Series A Read More »
For the past few years, TechCrunch has looked back at some of the worst, badly handled data breaches and security incidents in the hope — maybe! — other corporate giants would take heed and avoid making some of the same calamities of yesteryear. To absolutely nobody’s surprise, here we are again this year listing much
These were the badly handled data breaches of 2024 Read More »
For the past few years, TechCrunch has looked back at some of the worst, badly handled data breaches and security incidents in the hope — maybe! — other corporate giants would take heed and avoid making some of the same calamities of yesteryear. To absolutely nobody’s surprise, here we are again this year listing much
These were the badly handled data breaches of 2024 Read More »
23andMe announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at the company. The genetic testing company is also discontinuing its therapeutics business and winding down its clinical trials; it expects these changes to save $35 million annually. “We are taking these difficult but
23andMe cuts 40% of staff in restructuring Read More »
DNA and genetic testing firm 23andMe is in turmoil following a data breach last year and its ongoing financial decline. The once-pioneering giant now faces an uncertain future amid efforts to take the company private, intensifying concerns about what might happen to the genetic data of 23andMe’s some 15 million customers. Best known for its
23andMe faces an uncertain future — so does your genetic data Read More »
